Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
PaperCitations, authors & open-access status
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 57 citations, 2023 year and gold oa status.
57
Citations
2023
Year
gold
OA Status